Betta Pharmaceuticals Co., Ltd. (300558.SZ)
CNY 54.71
(0.66%)
CNY 54.71
(0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 914.22 Million | 306.73 Million | 526.63 Million | 646.02 Million | 555.07 Million | 286.39 Million |
| Net Income | 348.03 Million | 124.76 Million | 379.56 Million | 601.08 Million | 225.84 Million | 163.52 Million |
| Depreciation & Amortization | 303.48 Million | 253.7 Million | 174.46 Million | 155.15 Million | 142.76 Million | 99.2 Million |
| Deferred income taxes | -11.76 Million | -41.76 Million | -26.15 Million | -11.27 Million | -20.65 Million | -2.94 Million |
| Stock-based compensation | -16.46 Million | 132.52 Million | 75.96 Million | 32.08 Million | 28.35 Million | 16.68 Million |
| Change in working capital | 233.57 Million | -328.01 Million | -107.4 Million | 58.98 Million | 92.97 Million | -9.2 Million |
| Other non-cash items | 57.36 Million | 165.53 Million | 30.19 Million | -190.01 Million | 85.79 Million | 32.87 Million |
| Investing Cash Flow | -1.5 Billion | -1.32 Billion | -982.12 Million | -118.2 Million | -668.87 Million | -595.38 Million |
| Investments in PPE | -1.09 Billion | -1.01 Billion | -758.38 Million | -685.83 Million | -620.41 Million | -614.83 Million |
| Acquisitions | 22.21 Million | 685.76 Thousand | -190.36 Million | 259.74 Million | -17.3 Million | 614.96 Million |
| Investment purchases | -431.65 Million | -565.99 Million | -2.55 Billion | -414.69 Million | -38.59 Million | -103.54 Million |
| Sales/Maturities of investments | 409.43 Million | 251.51 Million | 2.51 Billion | 88.15 Million | 7.04 Million | 122.85 Million |
| Other Investing Activities | -409.43 Million | 0.73 | 238.01 Thousand | 634.42 Million | 392.44 Thousand | -614.83 Million |
| Financing Cash Flow | 608.19 Million | 941.51 Million | -95.55 Million | 314.48 Million | 323.81 Million | 394.69 Million |
| Debt repayment | -1.37 Billion | -1.03 Billion | -6.87 Million | -970 Million | -360 Million | -200 Million |
| Dividends payments | -29.22 Million | -103.84 Million | -128.08 Million | -76.19 Million | -44.11 Million | -82.56 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -736.76 Million | 2.11 Billion | 48.96 Million | 1.4 Billion | 778.57 Million | 677.26 Million |
| Accounts receivables | 174.19 Million | -198.29 Million | -181.6 Million | -15.64 Million | -11.19 Million | 5.24 Million |
| Accounts payables | 14.7 Million | -9.1 Million | 205.07 Million | 141.27 Million | 112.7 Million | 33.72 Million |
| Inventory | 44.67 Million | -78.85 Million | -104.72 Million | -55.36 Million | 12.11 Million | -45.23 Million |
| Other working capital | -16.46 Million | -41.76 Million | -26.15 Million | -11.27 Million | -20.65 Million | 36.03 Million |
| Cash at beginning of period | 731.28 Million | 791.98 Million | 1.34 Billion | 521.29 Million | 304.96 Million | 213.27 Million |
| Cash at end of period | 751.99 Million | 731.28 Million | 791.98 Million | 1.34 Billion | 521.29 Million | 304.96 Million |
| Capital Expenditure | -1.09 Billion | -1.01 Billion | -758.38 Million | -685.83 Million | -620.41 Million | -614.83 Million |
| Effect of forex changes on cash | 3.74 Million | 15.37 Million | -2.9 Million | -17.65 Million | 6.31 Million | 5.98 Million |
| Net cash flow / Change in cash | 20.71 Million | -60.7 Million | -553.95 Million | 824.64 Million | 216.32 Million | 91.69 Million |
| Free Cash Flow | -181.78 Million | -703.79 Million | -231.75 Million | -39.81 Million | -65.34 Million | -328.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 192.27 Million | 125.8 Million | 98.14 Million | 43.33 Million | 348.03 Million | 156.38 Million |
| Depreciation & Amortization | - | 83.89 Million | 83.89 Million | 81.32 Million | 303.48 Million | -140.84 Million |
| Deferred income taxes | - | 33.24 Million | - | -348.58 Million | -11.76 Million | 112.81 Million |
| Stock-based compensation | - | 53.28 Million | - | -16.46 Million | -16.46 Million | -49.91 Million |
| Change in working capital | - | 137.97 Million | - | 202.4 Million | 233.57 Million | 77.94 Million |
| Other non-cash items | 117.37 Million | 199.29 Million | 149.09 Million | 392.22 Million | 57.36 Million | 43.24 Million |
| Investing Cash Flow | -140.95 Million | -149.57 Million | -491.14 Million | -267.31 Million | -1.5 Billion | -349.28 Million |
| Investments in PPE | -145.85 Million | -148.42 Million | -313.77 Million | -266.83 Million | -1.09 Billion | -182.45 Million |
| Acquisitions | - | 140.36 Thousand | - | -263.67 Thousand | 22.21 Million | -143.98 Thousand |
| Investment purchases | 2.98 Million | -1.29 Million | -177.37 Million | -222.35 Thousand | -431.65 Million | -166.68 Million |
| Sales/Maturities of investments | 1.91 Million | - | - | 486.03 Thousand | 409.43 Million | 143.98 Thousand |
| Other Investing Activities | - | -1.15 Million | -177.37 Million | -486.03 Thousand | -409.43 Million | -143.98 Thousand |
| Financing Cash Flow | -33.21 Million | -214.65 Million | 47.57 Million | -27.05 Million | 608.19 Million | 181.63 Million |
| Debt repayment | -24.01 Million | -132.1 Million | -58.59 Million | -19 Million | -1.37 Billion | -50.01 Million |
| Dividends payments | - | -82.55 Million | -11.01 Million | -29.22 Million | -29.22 Million | -12.15 Million |
| Common Stock Repurchased | - | - | - | - | - | 18.99 Million |
| Common Stock Issuance | - | - | - | - | - | -18.99 Million |
| Other Financing Activities | -9.2 Million | -82.55 Million | -11.01 Million | -12.02 Million | -736.76 Million | 243.79 Million |
| Accounts receivables | - | 82.28 Million | - | 174.19 Million | 174.19 Million | 90.16 Million |
| Accounts payables | - | - | - | - | 14.7 Million | 40.29 Million |
| Inventory | - | 2.39 Million | - | 44.67 Million | 44.67 Million | -12.22 Million |
| Other working capital | - | 53.28 Million | - | -16.46 Million | -16.46 Million | -40.29 Million |
| Cash at beginning of period | 464.9 Million | 554.02 Million | 751.99 Million | 694.31 Million | 731.28 Million | 663.1 Million |
| Cash at end of period | 595.34 Million | 464.9 Million | 554.02 Million | 751.99 Million | 751.99 Million | 694.31 Million |
| Capital Expenditure | -145.85 Million | -148.42 Million | -313.77 Million | -266.83 Million | -1.09 Billion | -182.45 Million |
| Effect of forex changes on cash | - | 657.5 Thousand | -1.64 Million | -2.18 Million | 3.74 Million | -772.65 Thousand |
| Net cash flow / Change in cash | 130.43 Million | -89.11 Million | -197.97 Million | 57.68 Million | 20.71 Million | 31.2 Million |
| Free Cash Flow | 163.79 Million | 126.03 Million | -66.53 Million | 87.4 Million | -181.78 Million | 17.16 Million |
ABI
BNRE
HAZOOR
LAOPALA
0HVF
PRIC-B